Hisse Senetlerindeki Sıralama
#35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Hisse Fiyatı
$0.14942078
Son senkronizasyon: 2025-05-15
Ticaret Medigene AG (MDG1)
B piyasa değeri ile MDG1 fiyatı
Piyasa Değeri Medigene AG(MDG1)
Piyasa Değeri: $3.86M
August 2026 itibarıyla Medigene AG şirketinin piyasa değeri $3.86M. Bu, verilerimize göre Medigene AG şirketini dünyanın en değerli 35468th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Medigene AG piyasa değeri geçmişi (2000 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında MDG1
| MDG1’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.452T
|
+141,055,068.21%
|
|
|
|
|
$4.490T
|
+116,169,363.61%
|
|
|
|
|
$4.162T
|
+107,693,088.99%
|
|
|
|
|
$3.676T
|
+95,117,229.79%
|
|
|
|
|
$2.833T
|
+73,298,689.27%
|
